^
Association details:
Biomarker:ALK F1174L
Cancer:Neuroblastoma
Drug:AZD3463 (ALK inhibitor, IGF-1R inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Title:

Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis

Excerpt:
...ALK inhibitor AZD3463 can significantly suppress the viability of ALK WT and mutant NB cell lines and lead to tumor cell death in a dose-and time-dependent manners…Fig 1B…
DOI:
10.1038/srep19423